Background: The use of disease modifying treatments (DMTs) in multiple sclerosis (MS) has been well studied and has shown to reduce clinical relapses, MRI activity...
Read MoreBackground: The use of disease modifying treatments (DMTs) in multiple sclerosis (MS) has been well studied and has shown to reduce clinical relapses, MRI activity...
Read MoreBackground:: Eculizumab is a long-acting humanized monoclonal antibody targeted against complement C5. By preventing the cleavage of C5 into C5a and C5b, the deployment of...
Read MoreBackground: There is increased prevalence of genetic testing within the field of neurology and provider awareness of genetic conditions mimicking common neurological disorders, such as...
Read MoreBackground: Bilateral involvement and severe visual impairment can occur in the acute phase of pediatric myelin oligodendrocyte glycoprotein (MOG) antibody-associated optic neuritis (ON), but patients...
Read MoreBackground: High-dose corticosteroids (CS) (1g IV methylprednisolone or 1250 mg oral prednisone for 3-5 days) is the most common treatment currently used to treat acute...
Read MoreBackground: COVID 19 virus can infect the central and peripheral nervous system with or without other systemic manifestations of infection. SARS-CoV-2 interacts with the ACE-2...
Read MoreBackground: Spasticity is present among 60-80% of individuals with Multiple Sclerosis (Etoom et al, 2018). One-third of people with Multiple Sclerosis (MS) may experience spasticity...
Read MoreBackground: The association of multiple sclerosis (MS) and neurofibromatosis type 1 (NF1) has been rarely reported. Objectives: To report a case of MS associated with...
Read MoreBackground: MOG antibody-associated disease (MOGAD) is an inflammatory demyelinating disorder characterized by IgG antibodies against myelin oligodendrocyte glycoprotein (MOG). Distinct from both multiple sclerosis (MS)...
Read MoreBackground: There is a need for exercise strategies that maximize motor function and related changes in the central nervous system for people with progressive multiple...
Read MoreBackground: Multiple sclerosis (MS) is the most common autoimmune demyelinating disease of the central nervous system (CNS). It is an inflammatory disease affecting mostly young...
Read MoreBackground: Tinea corporis is a fungal infection of the skin excluding the face, hands, feet, scalp, nail, or groin. It mostly affects the immunocompromised host....
Read More3 University Plaza Drive, Ste 116
Hackensack, NJ 07601
(201) 487-1050
info@mscare.org
© 2021 CMSC